famotidine has been researched along with Neutropenia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oymak, O | 1 |
| Akpolat, T | 1 |
| Arik, N | 1 |
| Yasavul, U | 1 |
| Turgan, C | 1 |
| Caglar, S | 1 |
1 other study available for famotidine and Neutropenia
| Article | Year |
|---|---|
Reversible neutropenia and thrombocytopenia during famotidine treatment.
Topics: Famotidine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1994 |